The majority of used animal dementia models were transgenic, overexpressing or producing mutant products of human genes such as amyloid precursor protein (APP) [Jiang et al., 2020; Zhou et al., 2020; Lin et al., 2021) and tau (Zhang et al., 2018)]. This evidence concerns the gene MAPT and dementia.